Literature DB >> 27099177

Laminopathies disrupt epigenomic developmental programs and cell fate.

Jelena Perovanovic1, Stefania Dell'Orso2, Viola F Gnochi3, Jyoti K Jaiswal1, Vittorio Sartorelli2, Corinne Vigouroux4, Kamel Mamchaoui5, Vincent Mouly5, Gisèle Bonne5, Eric P Hoffman6.   

Abstract

The nuclear envelope protein lamin A is encoded by thelamin A/C(LMNA) gene, which can contain missense mutations that cause Emery-Dreifuss muscular dystrophy (EDMD) (p.R453W). We fused mutated forms of the lamin A protein to bacterial DNA adenine methyltransferase (Dam) to define euchromatic-heterochromatin (epigenomic) transitions at the nuclear envelope during myogenesis (using DamID-seq). Lamin A missense mutations disrupted appropriate formation of lamin A-associated heterochromatin domains in an allele-specific manner-findings that were confirmed by chromatin immunoprecipitation-DNA sequencing (ChIP-seq) in murine H2K cells and DNA methylation studies in fibroblasts from muscular dystrophy patient who carried a distinctLMNAmutation (p.H222P). Observed perturbations of the epigenomic transitions included exit from pluripotency and cell cycle programs [euchromatin (open, transcribed) to heterochromatin (closed, silent)], as well as induction of myogenic loci (heterochromatin to euchromatin). In muscle biopsies from patients with either a gain- or change-of-functionLMNAgene mutation or a loss-of-function mutation in theemeringene, both of which cause EDMD, we observed inappropriate loss of heterochromatin formation at theSox2pluripotency locus, which was associated with persistent mRNA expression ofSox2 Overexpression ofSox2inhibited myogenic differentiation in human immortalized myoblasts. Our findings suggest that nuclear envelopathies are disorders of developmental epigenetic programming that result from altered formation of lamina-associated domains.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27099177      PMCID: PMC4939618          DOI: 10.1126/scitranslmed.aad4991

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  36 in total

1.  LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.

Authors:  S Shackleton; D J Lloyd; S N Jackson; R Evans; M F Niermeijer; B M Singh; H Schmidt; G Brabant; S Kumar; P N Durrington; S Gregory; S O'Rahilly; R C Trembath
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

Review 2.  Genome-nuclear lamina interactions and gene regulation.

Authors:  Jop Kind; Bas van Steensel
Journal:  Curr Opin Cell Biol       Date:  2010-05-03       Impact factor: 8.382

3.  An EDMD mutation in C. elegans lamin blocks muscle-specific gene relocation and compromises muscle integrity.

Authors:  Anna Mattout; Brietta L Pike; Benjamin D Towbin; Erin M Bank; Adriana Gonzalez-Sandoval; Michael B Stadler; Peter Meister; Yosef Gruenbaum; Susan M Gasser
Journal:  Curr Biol       Date:  2011-09-29       Impact factor: 10.834

4.  Impact on oxidative phosphorylation of immortalization with the telomerase gene.

Authors:  K Auré; K Mamchaoui; P Frachon; G S Butler-Browne; A Lombès; V Mouly
Journal:  Neuromuscul Disord       Date:  2007-03-23       Impact factor: 4.296

5.  Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration.

Authors:  Marina Bakay; Zuyi Wang; Gisela Melcon; Louis Schiltz; Jianhua Xuan; Po Zhao; Vittorio Sartorelli; Jinwook Seo; Elena Pegoraro; Corrado Angelini; Ben Shneiderman; Diana Escolar; Yi-Wen Chen; Sara T Winokur; Lauren M Pachman; Chenguang Fan; Raul Mandler; Yoram Nevo; Erynn Gordon; Yitan Zhu; Yibin Dong; Yue Wang; Eric P Hoffman
Journal:  Brain       Date:  2006-02-14       Impact factor: 13.501

6.  Expression of the myodystrophic R453W mutation of lamin A in C2C12 myoblasts causes promoter-specific and global epigenetic defects.

Authors:  Anne-Mari Håkelien; Erwan Delbarre; Kristine G Gaustad; Brigitte Buendia; Philippe Collas
Journal:  Exp Cell Res       Date:  2008-03-07       Impact factor: 3.905

7.  SWAN: Subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips.

Authors:  Jovana Maksimovic; Lavinia Gordon; Alicia Oshlack
Journal:  Genome Biol       Date:  2012-06-15       Impact factor: 13.583

8.  Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study.

Authors:  R A Röber; K Weber; M Osborn
Journal:  Development       Date:  1989-02       Impact factor: 6.868

9.  Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells.

Authors:  Bo Wen; Hao Wu; Yoichi Shinkai; Rafael A Irizarry; Andrew P Feinberg
Journal:  Nat Genet       Date:  2009-01-18       Impact factor: 38.330

10.  Design and analysis of ChIP-seq experiments for DNA-binding proteins.

Authors:  Peter V Kharchenko; Michael Y Tolstorukov; Peter J Park
Journal:  Nat Biotechnol       Date:  2008-11-16       Impact factor: 54.908

View more
  49 in total

1.  Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boys.

Authors:  Utkarsh J Dang; Michael Ziemba; Paula R Clemens; Yetrib Hathout; Laurie S Conklin; Eric P Hoffman
Journal:  Hum Mol Genet       Date:  2020-08-29       Impact factor: 6.150

2.  Extreme nuclear branching in healthy epidermal cells of the Xenopus tail fin.

Authors:  Hannah E Arbach; Marcus Harland-Dunaway; Jessica K Chang; Andrea E Wills
Journal:  J Cell Sci       Date:  2018-09-20       Impact factor: 5.285

3.  Suppression of Activated FOXO Transcription Factors in the Heart Prolongs Survival in a Mouse Model of Laminopathies.

Authors:  Gaelle Auguste; Priyatansh Gurha; Raffaella Lombardi; Cristian Coarfa; James T Willerson; Ali J Marian
Journal:  Circ Res       Date:  2018-01-09       Impact factor: 17.367

4.  Computational 3D genome modeling using Chrom3D.

Authors:  Jonas Paulsen; Tharvesh Moideen Liyakat Ali; Philippe Collas
Journal:  Nat Protoc       Date:  2018-04-26       Impact factor: 13.491

5.  Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy.

Authors:  Anne-Claire Guénantin; Imen Jebeniani; Julia Leschik; Erwan Watrin; Gisèle Bonne; Nicolas Vignier; Michel Pucéat
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

6.  Tissue-Specific Influence of Lamin A Mutations on Notch Signaling and Osteogenic Phenotype of Primary Human Mesenchymal Cells.

Authors:  Kseniya Perepelina; Polina Klauzen; Anna Kostareva; Anna Malashicheva
Journal:  Cells       Date:  2019-03-21       Impact factor: 6.600

Review 7.  Lamins and Lamin-Associated Proteins in Gastrointestinal Health and Disease.

Authors:  Graham F Brady; Raymond Kwan; Juliana Bragazzi Cunha; Jared S Elenbaas; M Bishr Omary
Journal:  Gastroenterology       Date:  2018-03-13       Impact factor: 22.682

8.  Active chromatin marks drive spatial sequestration of heterochromatin in C. elegans nuclei.

Authors:  Daphne S Cabianca; Celia Muñoz-Jiménez; Véronique Kalck; Dimos Gaidatzis; Jan Padeken; Andrew Seeber; Peter Askjaer; Susan M Gasser
Journal:  Nature       Date:  2019-05-22       Impact factor: 49.962

Review 9.  The shifting shape of genomes: dynamics of heterochromatin interactions at the nuclear lamina.

Authors:  Victoria E Hoskins; Kristiana Smith; Karen L Reddy
Journal:  Curr Opin Genet Dev       Date:  2021-03-25       Impact factor: 5.578

10.  Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genes.

Authors:  Parisha P Shah; Wenjian Lv; Joshua H Rhoades; Andrey Poleshko; Deepti Abbey; Matthew A Caporizzo; Ricardo Linares-Saldana; Julie G Heffler; Nazish Sayed; Dilip Thomas; Qiaohong Wang; Liam J Stanton; Kenneth Bedi; Michael P Morley; Thomas P Cappola; Anjali T Owens; Kenneth B Margulies; David B Frank; Joseph C Wu; Daniel J Rader; Wenli Yang; Benjamin L Prosser; Kiran Musunuru; Rajan Jain
Journal:  Cell Stem Cell       Date:  2021-02-01       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.